› Cellendes.com (1 seconds ago)
› Techgateways.com (1 seconds ago)
› Dartmouthleisurecentre.com (3 seconds ago)
› Idc-ei.com (1 seconds ago)
› Englishmali.com (5 seconds ago)
› Dersturkce.com (2 seconds ago)
› Cursanocturnadelcastell.org (0 seconds ago)
› Churtongrove.org (3 seconds ago)
› Sailshoot.com (4 seconds ago)
› Psicoterapiaintegrativapnie.org (0 seconds ago)
› Kidsfirsttn.org (7 seconds ago)
› Creationjustice.org (2 seconds ago)
› Ustaokey.org (0 seconds ago)
› Submityourarticle.com (0 seconds ago)
› Heartlandpayroll.com (1 seconds ago)
› Pizetes.org (5 seconds ago)
› The-ocean.com (5 seconds ago)
› Mahwahtwp.org (0 seconds ago)
› Racacafeandbar.com (12 seconds ago)
› Mod.fyi (1 seconds ago)
We Found 9 domains on IP 22.214.171.124 listing below the same server this website
Cellendes.com search for results as listed below with the link list and email address for this website
Cellendes is a life science company offering comprehensive solutions for controlled design of cell environments in 3-D cell culture. A toolbox of reagents provides flexibility in composing biomimetic hydrogels right at the users bench.
Link: https://www.cellendes.com/ (Actived: Thursday Feb 7, 2019)
Link: https://www.asone-int.com/brand/cellendes/ (Actived: Monday Feb 4, 2019)
AS ONE INTERNATIONAL is proud to bring you two brands of distinct hydrogels for 3-D cell culture: Cellendes, a life science company in Germany, developed a biomimetic dextran-based hydrogel while Menicon Life Science in Japan manufactures a peptide-based hydrogel.
Link: https://www.asone-int.com/ (Actived: Thursday Feb 14, 2019)
CellGenix was the first company to obtain a GMP manufacturing authorization for therapeutic cell processing in Europe. Being an ATMP manufacturer ourselves allowed us to gain in-depth cell culture knowledge and superior regulatory expertise.
Link: https://cellgenix.com/ (Actived: Friday Feb 15, 2019)
Cellendes and EU partners develop cell therapy for treating type 1 diabetes. Cells derived from suitable donor stem cells that can do the work defective insulin-producing cells can no longer do are the central focus of a European cell therapy project involving Reutlingen-based Cellendes GmbH as one of the partners.
Link: https://www.gesundheitsindustrie-bw.de/en/article/news/cellendes-und-eu-partner-entwickeln-zelltherapie-fuer-diabetes-typ-1/ (Actived: Tuesday Feb 5, 2019)
Link: https://biopharmguy.com/company.php/Cellendes (Actived: Sunday Feb 10, 2019)
Cellendes puts paradigm change in cell research to good use Modern cell biology would be inconceivable without cell cultures . Several thousand cell lines from humans and from more than 150 animal species are cultivated outside the original organisms under controlled conditions in laboratories around the world.
Link: https://www.gesundheitsindustrie-bw.de/en/article/news/cellendes-puts-paradigm-change-in-cell-research-to-good-use/ (Actived: Monday Feb 11, 2019)
Link: http://www.qbioscience.com/productShow_537.html (Actived: Thursday Feb 14, 2019)
Next Generation Bioprinting. 3D bioprinting is a key technology to resolve a variety of medical challenges. 3D printed cell structures simulating human tissues and organs are changing the way drugs are designed.
Link: https://cellbricks.com/ (Actived: Friday Feb 15, 2019)
Link: https://www.centogene.com/ (Actived: Wednesday Feb 13, 2019)
Link: http://qbioscience.com/ (Actived: Wednesday Feb 13, 2019)
3D Hydrogels In Cell Culture Market segmentations by key players - UPM Global, AMS Biotechnology (Europe) Limited, 3D Biotek LLC, 3D Biomatrix, Inc., Becton, Dickinson and Company, Corning Inc., Global Cell Solutions, Inc., InSphero AG, Lonza Group AG, Nanofiber Solutions LLC, Boca Scientific, Inc., Esi Bio, Reinnervate Limited, Sigma-Aldrich Corp, Ferentis, Tecan Trading AG, Cellendes GmbH
Link: https://www.persistencemarketresearch.com/market-research/3d-hydrogels-in-cell-culture-market.asp (Actived: Wednesday Feb 13, 2019)
celares GmbH is a specialist for the delivery and enhancement of biologics with a proven track record in the development of PEGylated biologics, biosimilars, chemically modified drugs and ADCs, respectively. We provide customized solutions from development to production including reagents, development services and GMP products.
Link: https://www.celares.com/ (Actived: Tuesday Feb 12, 2019)